EMCDDA Home
  • EN
Search

Stay informed

Follow us on Twitter

Follow us on 

Subscribe to RSS news feed RSS feed

Media support

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:

Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 211 21 03 80

Maria José Louro
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 211 21 03 80

New EMCDDA Scientific Committee to start fresh mandate in January 2014

EU drugs agency announces Scientific Committee line-up for next three years

Lisbon, 20.12.2013 (Fact sheet No 13/2013)

Download fact sheet

Word
Download this attachment in DOC format
PDF
Download this attachment in PDF format

On 5 December, the EMCDDA Management Board appointed 15 high-level scientists to serve on the agency’s Scientific Committee for the period 2014–16. The selection followed a call for expressions of interest in the Official Journal of the European Union in February this year which yielded 79 eligible applications. The new members have been informed today of the Management Board’s decision. The mandate of the current Committee draws to a close at the end of 2013.

The 15 members — selected from the EU Member States and Norway — were chosen, following a public selection process, on the basis of scientific merit and independence and their expertise in the most relevant scientific fields linked to the problems of drugs and drug addiction today. One third of the scientists appointed are new members, while 10 previously served on the Committee. As members are appointed in a personal capacity, they are required to give their opinions independently of their country and of the Community institutions.

The Scientific Committee plays a major role in the EMCDDA’s efforts to attain scientific excellence. The agency consults the Committee on the quality of its work programmes and on any scientific matter concerning its activity, which the Management Board or the Director may submit to it. The Committee also plays a pivotal role in the agency’s risk assessment of new psychoactive substances.

The Management Board invited the Chair (Marina Davoli) and Vice-Chair (Gerhard Bühringer) of the outgoing Committee to continue acting in these roles until elections take place at the first meeting of the new Committee in Spring 2014. In addition to appointing the members of the new Committee, the Board also established a reserve list.

The EMCDDA thanks the outgoing Committee members for their role as guardians and advocates of the scientific integrity of the agency over two consecutive terms (2008–10 and 2011–13).

 

New Scientific Committee Gender Nationality
Henri BERGERON M French
Anne Line BRETTEVILLE-JENSEN F Norwegian
Gerhard BÜHRINGER M German
Catherine COMISKEY* F Irish
Paul DARGAN* M British
Marina DAVOLI F Italian
Brice DE RUYVER M Belgian
Gabriele FISCHER* F Austrian
Henk GARRETSEN M Dutch
Matthew HICKMAN M British
Dirk KORF  M Dutch
Krzysztof KRAJEWSKI M Polish
Letizia PAOLI* F Italian
Fernando RODRIGUEZ DE FONSECA M Spanish
Rainer SPANAGEL* M German

* denotes new member.

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Contact us

EMCDDA
Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Tuesday, 07 January 2014